Pela

Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC

Retrieved on: 
Friday, November 3, 2023
Neoplasm, PD-L1, Pela, Society for Immunotherapy of Cancer, Gastrointestinal cancer, Architecture, AB, SITC, Immunotherapy, Pelareorep, Cancer, Breast cancer, Annual general meeting, Pancreatic cancer, Tumor microenvironment, Society, Find, ONC, Patient, TSX, SAN, Pharmaceutical industry, Medical imaging, Oncolytics Biotech, IMC

"Using the novel IMC technology to conduct further translational data analysis from the AWARE-1 study in early-stage breast cancer patients has confirmed and expanded our understanding of pelareorep's mechanism of action in the tumor microenvironment," said Dr. Matt Coffey, President and Chief Executive Officer of Oncolytics.

Key Points: 
  • "Using the novel IMC technology to conduct further translational data analysis from the AWARE-1 study in early-stage breast cancer patients has confirmed and expanded our understanding of pelareorep's mechanism of action in the tumor microenvironment," said Dr. Matt Coffey, President and Chief Executive Officer of Oncolytics.
  • "We look forward to incorporating these important translational learnings into our registrational program for HR+/HER2- metastatic breast cancer.
  • These findings likely also have implications for other indications where we have seen signals of efficacy with atezolizumab/pelareorep combinations, including pancreatic cancer in the GOBLET study focused on gastrointestinal cancers."
  • This supports pelareorep's ability to modify the tumor microenvironment and enhance the responsiveness of cancers to checkpoint inhibitor therapy."

Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC

Retrieved on: 
Friday, November 3, 2023
Neoplasm, PD-L1, Pela, Society for Immunotherapy of Cancer, Gastrointestinal cancer, Architecture, AB, SITC, Immunotherapy, Pelareorep, Cancer, Breast cancer, Annual general meeting, Pancreatic cancer, Tumor microenvironment, Society, Find, ONC, Patient, TSX, SAN, Pharmaceutical industry, Medical imaging, Oncolytics Biotech, IMC

"Using the novel IMC technology to conduct further translational data analysis from the AWARE-1 study in early-stage breast cancer patients has confirmed and expanded our understanding of pelareorep's mechanism of action in the tumor microenvironment," said Dr. Matt Coffey, President and Chief Executive Officer of Oncolytics.

Key Points: 
  • "Using the novel IMC technology to conduct further translational data analysis from the AWARE-1 study in early-stage breast cancer patients has confirmed and expanded our understanding of pelareorep's mechanism of action in the tumor microenvironment," said Dr. Matt Coffey, President and Chief Executive Officer of Oncolytics.
  • "We look forward to incorporating these important translational learnings into our registrational program for HR+/HER2- metastatic breast cancer.
  • These findings likely also have implications for other indications where we have seen signals of efficacy with atezolizumab/pelareorep combinations, including pancreatic cancer in the GOBLET study focused on gastrointestinal cancers."
  • This supports pelareorep's ability to modify the tumor microenvironment and enhance the responsiveness of cancers to checkpoint inhibitor therapy."

New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action

Retrieved on: 
Thursday, June 8, 2023
PDAC, TNBC, Communication, Chronic lymphocytic leukemia, Precigen, Doctor of Philosophy, Investigational New Drug, GILD, MD, Patient, NYSE, News, Bone marrow, CLL, University, Oncolytics Biotech, Acute lymphoblastic leukemia, DLBCL, NK, Research, MD Anderson Cancer Center, B-cell lymphoma, Gilead, GSK plc, ONC, TSX, PD-1, FDA, Pancreatic cancer, GSK, Gilead Sciences, Trinket, Pela, ALL, Cancer, ACT Biotech Inc, National Cancer Institute, Standard of care, Therapy, ORR, Inflammation, Pelareorep, Triple-negative breast cancer, Cell death, Paclitaxel, Dostarlimab, Mantle cell lymphoma, MCL, FTD, Breast cancer, Pharmaceutical industry, Medical imaging, Cryptocurrency, EU, Dragonfly, Agency

VANCOUVER, British Columbia, June 8, 2023 /PRNewswire/ -- USA News Group - By utilizing newly developed novel mechanisms, biotech researchers and scientists are making strides in the battle against cancer. A study put out by researchers at the University of Texas MD Anderson Cancer Center recently detailed a previously unexplained type of cell death that could open the door for novel cancer therapies. How we arm ourselves in the battle against cancer is rapidly changing, thanks to novel mechanisms giving important results, such as those from Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Gilead Sciences, Inc. (NASDAQ: GILD), iTeos Therapeutics, Inc. (NASDAQ: ITOS), GSK plc (NYSE: GSK), and Precigen, Inc. (NASDAQ: PGEN).

Key Points: 
  • VANCOUVER, British Columbia, June 8, 2023 /PRNewswire/ -- USA News Group - By utilizing newly developed novel mechanisms, biotech researchers and scientists are making strides in the battle against cancer.
  • A study put out by researchers at the University of Texas MD Anderson Cancer Center recently detailed a previously unexplained type of cell death that could open the door for novel cancer therapies.
  • At this year's Future of Oncology Virtual Symposium in early April, Oncolytics was selected to participate in a panel presentation called Novel Mechanisms with Important Readouts.
  • Pelareorep's impacts on cancer are also being researched, including through Oncolytics' first and longest-standing focus on its HR-positive HER2-negative metastatic breast cancer program.

New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action

Retrieved on: 
Thursday, June 8, 2023
PDAC, TNBC, Communication, Chronic lymphocytic leukemia, Precigen, Doctor of Philosophy, Investigational New Drug, GILD, MD, Patient, NYSE, News, Bone marrow, CLL, University, Oncolytics Biotech, Acute lymphoblastic leukemia, DLBCL, NK, Research, MD Anderson Cancer Center, B-cell lymphoma, Gilead, GSK plc, ONC, TSX, PD-1, FDA, Pancreatic cancer, GSK, Gilead Sciences, Trinket, Pela, ALL, Cancer, ACT Biotech Inc, National Cancer Institute, Standard of care, Therapy, ORR, Inflammation, Pelareorep, Triple-negative breast cancer, Cell death, Paclitaxel, Dostarlimab, Mantle cell lymphoma, MCL, FTD, Breast cancer, Pharmaceutical industry, Medical imaging, Cryptocurrency, EU, Dragonfly, Agency

VANCOUVER, British Columbia, June 8, 2023 /PRNewswire/ -- USA News Group - By utilizing newly developed novel mechanisms, biotech researchers and scientists are making strides in the battle against cancer. A study put out by researchers at the University of Texas MD Anderson Cancer Center recently detailed a previously unexplained type of cell death that could open the door for novel cancer therapies. How we arm ourselves in the battle against cancer is rapidly changing, thanks to novel mechanisms giving important results, such as those from Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Gilead Sciences, Inc. (NASDAQ: GILD), iTeos Therapeutics, Inc. (NASDAQ: ITOS), GSK plc (NYSE: GSK), and Precigen, Inc. (NASDAQ: PGEN).

Key Points: 
  • VANCOUVER, British Columbia, June 8, 2023 /PRNewswire/ -- USA News Group - By utilizing newly developed novel mechanisms, biotech researchers and scientists are making strides in the battle against cancer.
  • A study put out by researchers at the University of Texas MD Anderson Cancer Center recently detailed a previously unexplained type of cell death that could open the door for novel cancer therapies.
  • At this year's Future of Oncology Virtual Symposium in early April, Oncolytics was selected to participate in a panel presentation called Novel Mechanisms with Important Readouts.
  • Pelareorep's impacts on cancer are also being researched, including through Oncolytics' first and longest-standing focus on its HR-positive HER2-negative metastatic breast cancer program.

Ten Leaders Recognized as 2022 SEAL Sustainability Leader Award Winners

Retrieved on: 
Monday, September 5, 2022
Adidas, Engineering, Sustainability, Plant, Global Sustainability Assessment System, Technology, Research, Solution, Biophysical environment, Pela, Grist, Kruger, SEAL, Organization, Cisco Systems, Leadership, Certification, AMD, Climate change, Environment, GHG, Management, Civil engineering, Guardian, The New York Times

SAN DIEGO, Calif., Sept. 5, 2022 /PRNewswire-PRWeb/ -- SEAL has announced the ten winners of its 2022 Sustainability Leadership Awards, an ESG leadership award honoring the top executive leaders in Sustainability, EHS, and CSR.

Key Points: 
  • Knowing I'm doing something good for people and planet is what gets me up every morning, and that is a great feeling."
  • - former Global Sustainable Sourcing Lead, Oatly
    "Thank you very much for highlighting the role of sustainability leadership!
  • For companies interested in entering our 2022 SEAL Business Sustainability Awards, please register below:
    2022 SEAL Business Sustainability Award: https://sealawards.com/apply-2022/
    2022-2023 SEAL Sustainability Leader Award Nominations:
    Nominations for 2022-2023 can be submitted at: https://sealawards.com/2022-seal-sustainability-leader-award/
    SEAL (Sustainability, Environmental Achievement & Leadership) Awards is an environmental advocacy organization that honors leadership through our business sustainability awards & environmental journalism awards while funding research and pursuing our own environmental impact campaigns.
  • The SEAL Awards core pillars are:
    Business Sustainability Awards honors the most sustainable companies in the world, like Adidas, AMD, Cisco, and Tide
    Environmental Journalism Awards representative past winners include journalists from Guardian, New York Times, and Grist

On a Mission to Tackle Waste in the Beauty Industry, MOB Beauty Will Offer Fully Compostable Packaging by 2024

Retrieved on: 
Wednesday, June 15, 2022
Solution, Time, Beauty, Education, Industry, Fiat Albea, Credo, MOB, Earth First!, PP, Compact, Golden Arrow, PET, Pela, Research, Capsule, Repurposing, Work, Hudson, Recycling, Compact fluorescent lamp, Partnership, Plastic, Bay, Collection, PCR, Food industry, Cosmetics, Pact

PALM SPRINGS, Calif., June 15, 2022 /PRNewswire/ -- MOB Beauty , a sustainable makeup brand focused on pro-quality makeup and innovative Earth-friendly packaging, has announced their commitment to offer NewPurpose, a collection of fully compostable beauty packaging, by 2024.

Key Points: 
  • PALM SPRINGS, Calif., June 15, 2022 /PRNewswire/ -- MOB Beauty , a sustainable makeup brand focused on pro-quality makeup and innovative Earth-friendly packaging, has announced their commitment to offer NewPurpose, a collection of fully compostable beauty packaging, by 2024.
  • Dedicated to continuous innovation and with sights set on compostable end-of-life solutions, the team at MOB has dedicated three years of work and countless iterations developing NewPurpose.
  • With this initiative, MOB is officially recognized as a Lomi Approved partner and NewPurpose is authorized as fully compatible for use with the device.
  • The collaboration signifies what will be the first of many efforts to have a meaningful impact on waste from beauty packaging.

Lomi, Revolutionary At-Home Composting Appliance, Now Available at Best Buy

Retrieved on: 
Tuesday, May 17, 2022
News, Sale, Pela, Solution, History, Soil, Tree, GLOBE, Coal, Environment, Best Buy, Food, Plastic, Grocery store, Recycling

With more than eight million tons of plastic ending up in landfills annually, Lomi users can take actionable steps to directly eliminate waste right from their kitchen counter.

Key Points: 
  • With more than eight million tons of plastic ending up in landfills annually, Lomi users can take actionable steps to directly eliminate waste right from their kitchen counter.
  • Lomi speeds up the breakdown of organic waste into smaller fragments, similar to how earthworms break down and mix plant tissue into soil.
  • "We are thrilled that eco-conscious consumers will have the opportunity to purchase Lomi at Best Buy stores across America," said Pela CEO Matt Bertulli.
  • The revolutionary device breaks down biodegradable waste, like food and certain plastics, at the push of a button.

Canada’s Robotics Start-Up Trendi Makes South By Southwest Debut, March 15 - 19

Retrieved on: 
Thursday, March 10, 2022
Industry, Solution, CMO, Skag Trendy (song), AR, Food, Dario Campeotto, Entrepreneurship, Pela, Vegetable, Robotics, SXSW, Communications satellite

This solution is targeted to upcycle mass amounts of misfit and excess food before it goes to waste.

Key Points: 
  • This solution is targeted to upcycle mass amounts of misfit and excess food before it goes to waste.
  • Additionally, the event will feature a mobile game tournament and AR activation to encourage conversation and sharing about food waste issues.
  • Campeotto will discuss the brands innovative robotics technology and roadmap to reducing food waste at its source.
  • Trendis participation in SXSW takes place throughout Austin, TX from March 15 - March 19, 2022.

Gadget Guard Renews Its Vision to Create Healthy Relationships Between Tech and Humanity in 2022

Retrieved on: 
Tuesday, January 11, 2022
Mobile, Wireless, Technology, Hardware, Radiation, Health, Technology, Wireless, AirTag, Human, CEO, Mental health, Pela, Alara, Environment, Mobile phone, Online shopping

Gadget Guard goes beyond traditional wireless accessories with its vision to create a healthy relationship between tech and humanity.

Key Points: 
  • Gadget Guard goes beyond traditional wireless accessories with its vision to create a healthy relationship between tech and humanity.
  • Were excited to launch more products in 2022 that will expand our two-way protection and help create a healthy relationship between tech and humanity.
  • All of Gadget Guards products put people first, committing to make tech devices healthier for humanity.
  • Gadget Guard fosters a healthy relationship between tech and humanity with products that improve the performance, aesthetic and lifespan of mobile devices.

Pela joins the ranks of sustainable companies as a certified B Corporation

Retrieved on: 
Wednesday, October 30, 2019
Benefit corporations, B Corporation, Product certification, Social economy, Social entrepreneurship, Pela, B Lab, Kelowna, Kasha, Economy

KELOWNA, BC, Oct. 30, 2019 /PRNewswire/ - Pela is on track to create a waste free future with their freshly minted Certified B Corporation status.

Key Points: 
  • KELOWNA, BC, Oct. 30, 2019 /PRNewswire/ - Pela is on track to create a waste free future with their freshly minted Certified B Corporation status.
  • "We're excited to welcome Pela to the community of Certified B Corporations, which is growing quickly with over 3,000 companies now certified globally and almost 300 in Canada, said country manager of Canada for B Lab, Kasha Huk.
  • "Through their commitment to creating a regenerative economy, Pela is demonstrating that business can be a force for good in the world, delivering purpose alongside profit.
  • "We went after B Corp because the alignment was already there, so it only made sense to become part of the remarkable B Corp network.